BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
Number Citing Articles
1 Butowt R, Meunier N, Bryche B, von Bartheld CS. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models. Acta Neuropathol 2021;141:809-22. [PMID: 33903954 DOI: 10.1007/s00401-021-02314-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 36.0] [Reference Citation Analysis]
2 Canavero I, Ravaglia S, Valentino F, Micieli G. Guillain Barrè syndrome and myelitis associated with SARS-CoV-2 infection. Neurosci Lett 2021;759:136040. [PMID: 34118307 DOI: 10.1016/j.neulet.2021.136040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang Y, Archie SR, Ghanwatkar Y, Sharma S, Nozohouri S, Burks E, Mdzinarishvili A, Liu Z, Abbruscato TJ. Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping. Fluids Barriers CNS 2022;19. [DOI: 10.1186/s12987-022-00339-7] [Reference Citation Analysis]
4 Deroubaix A, Kramvis A. Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection. Front Cell Infect Microbiol 2022;12:794264. [DOI: 10.3389/fcimb.2022.794264] [Reference Citation Analysis]
5 Schmitz Nunes V, Rogério AP, Abrahão O Jr. Insights into the Activation Mechanism of the ALX/FPR2 Receptor. J Phys Chem Lett 2020;11:8952-7. [PMID: 33030905 DOI: 10.1021/acs.jpclett.0c02052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Moscara L, Tafuri S, Gagliardi D, Stefanizzi P. Immunogenicity and safety of BNT162b2 mRNA COVID-19 vaccine in a subject affected by Shapiro's syndrome: A case report. Hum Vaccin Immunother 2022;:2094148. [PMID: 35763557 DOI: 10.1080/21645515.2022.2094148] [Reference Citation Analysis]
7 Hosseini N, Nadjafi S, Ashtary B. Overview of COVID-19 and neurological complications. Rev Neurosci 2021;32:671-91. [PMID: 33583157 DOI: 10.1515/revneuro-2020-0116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Francesca P, Mauro P, Clerbaux LA, Leoni G, Ponti J, Bogni A, Brogna C, Cristoni S, Sanges R, Mendoza-de Gyves E, Fabbri M, Querci M, Soares H, Munoz Pineiro A, Whelan M, Van de Eede G. Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: possible implications for SARS-CoV-2 impact on brain development. Reprod Toxicol 2022:S0890-6238(22)00060-0. [PMID: 35525527 DOI: 10.1016/j.reprotox.2022.04.011] [Reference Citation Analysis]
9 Diep PT. Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? Med Hypotheses 2021;146:110360. [PMID: 33214002 DOI: 10.1016/j.mehy.2020.110360] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bilinska K, von Bartheld CS, Butowt R. Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19. bioRxiv 2021:2021. [PMID: 33880469 DOI: 10.1101/2021.04.11.439398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dadkhah M, Talei S, Doostkamel D, Molaei S, Rezaei N. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review. Rev Neurosci 2021. [PMID: 34087964 DOI: 10.1515/revneuro-2020-0154] [Reference Citation Analysis]